Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma
-
Published:2024-08
Issue:8
Volume:9
Page:103645
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Dufresne A., Pokras S., Meurgey A., Chabaud S.ORCID, Toulmonde M., Bompas E.ORCID, Le Cesne A., Robin Y.-M., Duffaud F., Valentin T.ORCID, El Zein S., Leroux A.ORCID, Dubray-Longeras P., Firmin N.ORCID, de Pinieux G., Noal S., Delfour C.ORCID, Bollard J., Tonon L.ORCID, Biette A., Gadot N.ORCID, Attignon V., Jean-Denis M.ORCID, Woessner M., Klohe E., Thayaparan T., Eleftheriadou I., Blouch K., Nathenson M.J.ORCID, Blay J.-Y.ORCID
Funder
GlaxoSmithKline Plc
|
|